GSK candidate vaccine helps prevent active pulmonary tuberculosis in HIV negative adults
Publication of primary results in the New England Journal of Medicine shows positive impact of innovative vaccine technology in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AstraZeneca announces positive results from Phase III DECLARE-TIMI 58
Forxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000…
Dr Manoj Nerurkar, COO steps down from role at Syngene
The announcement of the appointment of his successor will be made shortly
Netmeds strengthens its healthcare expertise with acquisition of JustDoc.com
With this acquisition, Netmeds marks its entry into the diagnostics, offering end-to-end consultancy in the healthcare, lifestyle…
Novartis to cut 2,200 jobs in Switzerland to boost profitability
About 1,500 positions will be cut from Novartis's production sites in Basel, Stein, Locarno and Schweizerhalle
EU approves AstraZeneca immunotherapy drug for lung cancer
The green light from the EU had been expected following a positive recommendation from experts at the European Medicines Agency
USFDA completes inspection of Biocon’s drug substance unit at Bengaluru
The week-long audit concluded without any observations and no Form 483 was issued
Our research aims to develop low-cost efficient anti-cancer therapeutic options: Dr P Gopinath
IIT Roorkee Professor Dr P Gopinath discusses about developing an economical and green way to detect and kill cancer cells and how…
Kaisha launches Kaisha Lifesciences at Daman, India
In addition to the products offered by Kaisha Lifesciences, the new set-up will offer a portfolio of contract research services…
Bayer says Monsanto India integration to complete in one year
Bayer completed the deal to acquire US-based Monsanto recently and the acquisition of Monsanto has been completed globally but it…